Preterm newborn trials found blood-pressure improvements without demonstrated survival benefits
Some medicines helped resolve low blood pressure, while survival benefits remained unproven and adverse effects differed across treatments.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
In very preterm newborns, dopamine and hydrocortisone improved resolution of low blood pressure compared with placebo. The review did not demonstrate better survival or neurodevelopment with drug treatment. Reported harms included more brain bleeding with dopamine and more high blood sugar with hydrocortisone. Better blood-pressure responses therefore did not establish broader clinical benefit.
The abstract omits follow-up durations and absolute event counts. Lack of demonstrated survival or neurodevelopmental benefit does not establish equal treatment effects.
What researchers found
Resolution of low blood pressure
Dopamine versus placebo: resolution odds were 4.53 times as high. Odds compare the chances of resolving and remaining unresolved; this does not mean 4.53 times the probability of resolution. The confidence interval expresses uncertainty; assessment timing was not reported.
Blood pressure and clinical outcomes
The review examined both resolution of low blood pressure and outcomes such as survival and neurodevelopment. Improvement in the immediate physiological measure did not come with demonstrated benefit in these broader outcomes.
Harms differed by medicine
Compared with placebo, dopamine was linked to more intraventricular haemorrhage, or bleeding into the brain's ventricles. Hydrocortisone was linked to more hyperglycemia, or high blood sugar, also compared with placebo.
The original publication
Pharmacological Hypotensive Treatment in Very Preterm Newborns: Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Boscarino G, Conti MG, Esposito S et al.
Acta Paediatr · 2026
- PubMed ID
- 41353557
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.